Procaine For Local Anesthesia CAS:59-46-1

   What Procaine Powder Is: The Pure Crystalline Foundation

    Procaine powder is the purified, freebase form of Procaine Hydrochloride (chemical name: 2-(diethylamino)ethyl 4-aminobenzoate). While procaine hydrochloride is the water-soluble salt commonly formulated into injectable solutions, procaine powder refers to the isolated crystalline compound before salt formation. It appears as a fine, white to off-white, odorless crystalline powder. This raw material is the essential starting point for compounding pharmacists and specialized medical practitioners who require bespoke formulations not available commercially. Its existence hinges on the chemical synthesis process, where the freebase is initially formed and then typically converted to the hydrochloride salt for stability and solubility in standard medical preparations. Procaine powder itself is highly lipophilic (fat-soluble) and has very limited solubility in water, a critical factor influencing its formulation.

 

    ●Ultimate Purity Control: As the raw material, the powder allows direct verification and control over the procaine compound itself, free from excipients (preservatives, antioxidants, buffers) found in commercial injections. This is paramount for individuals with sensitivities to common additives like methylparaben or metabisulfite.

    ●Formulation Flexibility: This is the cardinal advantage. Practitioners can dissolve the powder in precisely chosen vehicles:

    ○Sterile Water/Saline: Creates a simple, additive-free solution. Requires careful pH adjustment (see below).

    ○Specific pH Buffers: Allows tailoring the pH to optimize the proportion of non-ionized (lipid-soluble, membrane-penetrating) procaine molecules, potentially speeding onset and reducing injection pain. The natural pKa of procaine (~8.9) means it's predominantly ionized at physiological pH (7.4), limiting penetration. Raising the pH closer to the pKa increases the non-ionized fraction.

    ○Vasoconstrictor Solutions: Can be dissolved directly in dilute epinephrine (e.g., 1:200,000 or 1:100,000) or other vasoconstrictors (phenylephrine) solutions prepared for this purpose, ensuring homogenous mixing at the molecular level from the start.

    ○Combination Solutions: Enables creation of bespoke mixtures, such as combining procaine with a small amount of a more potent, longer-acting amide anesthetic (like lidocaine) for tailored onset/duration profiles, or with corticosteroids for specific therapeutic blocks.

    ●Concentration Customization: Allows preparation of solutions at exact concentrations needed for specific, often off-label, applications (e.g., very dilute solutions for specific nerve blocks or IV regional techniques).

    ●Reduced Preservative Load: Enables formulation of preservative-free solutions for single-use applications, eliminating potential irritants.

    ●Stability Considerations: While the hydrochloride salt in solution has defined stability, the freebase powder itself is relatively stable when stored correctly (cool, dry, dark, airtight). However, compounded solutions made from powder may have shorter beyond-use dates compared to commercially manufactured, multi-dose vials containing preservatives and stabilizers, unless aseptically prepared and terminally sterilized.

    Procaine powder's use is primarily in specialized medical and veterinary compounding:

    ●Custom Dental Anesthesia: For dentists managing patients with severe allergies to preservatives (e.g., methylparaben) or sulfites commonly found in commercial cartridges. Allows creation of preservative-free solutions tailored to specific procedures.

    ●Specialized Nerve Blocks: In pain management or surgery, creating specific concentrations or pH-adjusted solutions for blocks where procaine's relatively short duration and low systemic toxicity profile are advantageous (e.g., diagnostic blocks, Bier blocks for IV regional anesthesia).

    ●Compounding for Specific Allergies: When a patient has confirmed allergies to amide anesthetics (lidocaine, bupivacaine, etc.) but tolerates esters, procaine powder becomes essential for creating a safe, custom local anesthetic solution.

    ●Veterinary Medicine: Widely used by compounding pharmacists to create specific concentrations and formulations suitable for different animal species and sizes, often incorporating vasoconstrictors at precise ratios.

    ●Historical & Niche Therapeutic Uses: While largely superseded for systemic effects, procaine powder was historically the source for "procaine hydrochloride" used in IV "procaine therapies" (e.g., "Gerovital H3" variants) for various purported benefits (largely unsubstantiated by robust modern evidence). Powder form is necessary for compounding such preparations. Its use in mesotherapy formulations also relies on the powder.

    ●Research & Development: Essential for creating novel delivery systems (liposomes, microspheres) or studying fundamental properties of the procaine molecule without formulation excipients interfering.

    Using procaine powder leverages the inherent characteristics of the procaine molecule, amplified by formulation control:

    ●Low Systemic Toxicity: Procaine has a significantly higher therapeutic index (ratio of toxic dose to effective dose) compared to many amide anesthetics, primarily due to its rapid hydrolysis by plasma cholinesterase. This makes it relatively safer, especially in settings where systemic absorption might be higher or in patients with compromised metabolism for amides.

    ●Rapid Metabolism: Esterase hydrolysis in plasma and the liver results in rapid breakdown to para-aminobenzoic acid (PABA) and diethylaminoethanol (DEAE). This minimizes the risk of cumulative toxicity and allows for repeated dosing or infusion with closer monitoring than longer-acting agents. PABA is a known allergen, however.

    ●Vasodilatory Properties: Procaine inherently causes vasodilation. While this can lead to faster systemic absorption and shorter duration, it enables the practitioner using powder to precisely control the degree and timing of vasoconstriction by adding exactly the desired amount and type of vasoconstrictor (e.g., epinephrine) during formulation. This allows optimization for both hemostasis and duration extension.

    ●Reduced Allergenicity (to the Anesthetic Core): True IgE-mediated allergy to the procaine molecule itself is exceedingly rare. Most "allergic" reactions to procaine solutions are due to the metabolite PABA or to preservatives (methylparaben, which is structurally similar to PABA). Powder formulation avoids preservative-related reactions.

    ●Cost-Effectiveness (Bulk): For high-volume compounding (e.g., veterinary clinics), procaine powder can be more economical than purchasing large quantities of pre-filled cartridges or vials.

    Dosage is highly dependent on the formulation created from the powder and the application:

    ●Concentration: Typical injectable concentrations range from 0.25% to 2%. Higher concentrations (1-2%) are used for infiltration and nerve blocks requiring dense motor block. Lower concentrations (0.25-0.5%) are used for epidural or spinal anesthesia (though largely replaced by amides) or IV regional anesthesia (Bier block). Compounding allows precise in-between concentrations.

    ●Total Dose: The maximum recommended dose for plain procaine (without vasoconstrictor) is generally 6-7 mg/kg, not exceeding 400-500 mg total in a healthy adult. With epinephrine (1:200,000), the maximum dose increases to approximately 8-9 mg/kg, not exceeding 600-700 mg total.    Crucially, these are guidelines for the procaine component; the dose of any added vasoconstrictor (especially epinephrine) must be calculated separately and stay within safe limits.

    ●Onset & Duration: Onset of action is typically 5-10 minutes for infiltration/block. Duration of action for sensory block is relatively short:

    ○Plain Solution: 30-60 minutes.

    ○With Epinephrine (1:200,000): 60-90 minutes (due to reduced systemic absorption).

    ○Formulation via powder allows pH adjustment, potentially reducing onset time to 3-7 minutes by increasing the non-ionized fraction.

    ●Administration: Solutions compounded from powder are administered via standard techniques: local infiltration, peripheral nerve blocks, epidural, spinal (historically, less common now), and IV regional (Bier block). Sterile technique and aseptic compounding are non-negotiable. Solutions must be clear and free of particulate matter.

    The "cycle" refers to the pharmacokinetic journey of procaine after injection of a solution compounded from the powder:

    1.Absorption: Rate depends on vascularity of the injection site, concentration, presence of vasoconstrictor, and pH (affecting non-ionized fraction). Vasodilation caused by procaine promotes absorption unless counteracted by added vasoconstrictor.

    2.Distribution: Distributes into well-perfused tissues. Low protein binding (<6%) means most is free in plasma.

    3.Metabolism (Crucial for Esters): Rapidly hydrolyzed by plasma pseudocholinesterase (butyrylcholinesterase) in the blood and liver. The primary metabolites are:

    ○Para-Aminobenzoic Acid (PABA): A known contact allergen and potential hapten. Excreted renally.

    ○Diethylaminoethanol (DEAE): Further metabolized or excreted renally. Possesses weak CNS activity.

    4.Elimination Half-Life: Procaine has an extremely short plasma elimination half-life of approximately 30 - 60 seconds. This reflects the incredibly rapid rate of hydrolysis by plasma esterases. The metabolites have longer half-lives (hours) but are generally inactive or minimally active as local anesthetics and much less toxic. This rapid metabolism underpins procaine's favorable systemic toxicity profile compared to amides, which rely on hepatic metabolism with longer half-lives (e.g., lidocaine ~90 mins).

    5.Excretion: Renal excretion of the water-soluble metabolites (PABA, DEAE, and their conjugates) is the primary route.

    The plasma elimination half-life of 30-60 seconds is arguably procaine's most defining pharmacokinetic characteristic. This is orders of magnitude shorter than amide anesthetics (lidocaine 1.5-2h, bupivacaine 2-4h, ropivacaine 1-2h). It means:

    ●Rapid Clearance: Systemic levels plummet within minutes after absorption ceases.

    ●Low Accumulation Risk: Repeated doses or infusions carry a lower risk of cumulative systemic toxicity compared to amides.

    ●Metabolism Over Excretion: Clearance is primarily enzymatic (hydrolysis) rather than relying on hepatic blood flow or renal excretion for the parent compound.

    ●Dependence on Esterase Function: Patients with atypical plasma cholinesterase (genetic deficiency or inhibition by drugs like echothiophate or organophosphates) will have dramatically prolonged half-life and significantly increased risk of systemic toxicity, as hydrolysis is impaired. This is a critical contraindication.

Trade names	Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester; 4-aminobenzoic acid 2-diethylaminoethyl ester; PROCAINE; novocaine
CAS	59-46-1
Molar mass	236.315
MF	C13H20N2O2
Purity	Above 99%
Apprarance	White  Crystalline Powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    Procaine powder is not a first-line choice for routine local anesthesia where convenient, stable, long-acting amide solutions suffice. Its significance lies in its role as the foundational raw material for specialized compounding. It empowers practitioners to overcome limitations of commercial preparations: managing complex allergies (especially to preservatives or amides), creating precisely tailored concentrations and pH-adjusted solutions for optimal performance, formulating custom vasoconstrictor combinations, and enabling cost-effective bulk preparation for specific settings like veterinary medicine. While its short duration is a limitation, its rapid metabolism and low intrinsic systemic toxicity remain valuable assets, particularly when formulation control via the powder allows mitigation of its vasodilatory effects. Handling procaine powder demands rigorous adherence to sterile compounding practices, precise pharmacokinetic understanding (especially its fleeting half-life and PABA metabolite), and recognition of its specific indications. In the hands of skilled compounders and practitioners navigating unique clinical challenges, procaine powder remains a vital, albeit specialized, tool in the armamentarium of local anesthesia.

Hot Tags: procaine for local anesthesia cas:59-46-1, China procaine for local anesthesia cas:59-46-1 manufacturers, suppliers, factory, Anabolic steroid Methenolone Acetate, Boldenone Undecylenate, Boldenone Undecylenate wholesale price, Enhances muscle mass Testosterone Acetate, Sterid Raw Powders Orals, Testosterone Acetate